News

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

Nearly 7 million people in the U.S. are living with Alzheimer’s disease. That number is expected to double by the year 2060.

We’re talking about the important role of rehabilitation after amputation and the expertise at Saint Luke’s Rehabilitation Institute.